Board Decisions

GF/B37/DP12


Approved by the Board on:
04 May 2017


Amended and Restated Global Fund Quality Assurance Policy for Diagnostic Products

Based on the recommendation of the Strategy Committee, the Board approves the amended and restated Global Fund Quality Assurance Policy for Diagnostic Products, as set forth in Annex 1 to GF/B37/06.